The CR shambles has led to some serious fragility in the ANP share price, eliminating the majority of momentum achieved around christmas last year. To get back on track it is key that the directors get focussed on the science and provide the market with guidance on what is in the pipeline, and when!
If those who are more knowledgable could help, but what are the key projects/news flows we are expecting..
- Theres the ALL1103 trials expected to commence mid this year, and finalised late 2013
- mention of a partnership deal for ATL1103???
- Partnership deal with TJAB for ATL1102 (are there any project milestones mentioned for this?)
-......
The CR shambles has led to some serious fragility in the ANP...
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
